echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Biochemistry News > Biotechnology News > New methods for glaucoma treatment

    New methods for glaucoma treatment

    • Last Update: 2021-11-04
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    • Glaucoma is the main cause of blindness


    • At present, the only way to treat primary congenital glaucoma is surgery

    • New treatments are urgently needed to slow down the vision loss of both types of glaucoma

    Chicago News, a study conducted by Northwestern Medicine in mice has identified new treatment targets for glaucoma, including the prevention of a severe form of glaucoma in children, and the discovery of a possible treatment for the most common glaucoma in adults New type


    For people with high intraocular pressure glaucoma, the fluid in the eyes cannot be discharged normally, which puts pressure on the optic nerve and causes vision loss


    Although there are some of the most common adult glaucoma used to treat open-angle glaucoma (eye drops, oral medication, laser treatment), primary congenital glaucoma can only be treated with surgery


    "Although primary congenital glaucoma is much rarer than open-angle glaucoma, it is devastating for children," said the corresponding author, Dr.


    Through gene editing, the scientists in the study developed a new model of glaucoma in mice, similar to primary congenital glaucoma


    The research was published in the journal Nature Communications on October 18


    Quaggin said the next step is to develop a suitable delivery system for the new protein that successfully treats patients and put it into production


    In addition, scientists use bioinformatics and single-cell RNA sequence data to understand and identify the pathway of glaucoma.


    Quaggin said: "It would be great to have a treatment that promotes the remodeling and/or growth of the defective Schlemm’s tube to treat glaucoma


    "We hope that this research can lead the first targeted therapy to effectively promote the flow of (aqueous) fluid from the front of the eye and reverse the potential biological defects of glaucoma patients


    Nature Communications

    DOI

    10.


    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.